Cancer Research · 2004 · 381 citations · 16 references
MedicineCancer BiologyOncologyDrug DeliveryGene DeliveryMolecular OncologyAngiogenesisAngiogenesis In CancerRna InterferenceSmall Interfering Rna BiologySmall Interfering Rna DeliveryTargeted Cancer TherapyCancer Cell Line ModelsRna Interference TherapeuticsTargeted TransfectionTherapeutic Small Interfering RnaTransfection EfficiencyTransfection ReagentsVascular Endothelial Growth Factor InhibitionVascular Endothelial Growth Factor Inhibitors
VEGF is essential for embryonic angiogenesis and for pathological angiogenesis in diseases such as cancer. The study aimed to develop a novel VEGF blockade system via RNA interference. The system delivers siRNA targeting VEGF with atelocollagen to stabilize and efficiently transfect tumors. siRNA targeting VEGF nearly abolished VEGF secretion in PC‑3 cells and, when delivered with atelocollagen, markedly reduced tumor angiogenesis and growth in a PC‑3 xenograft model.
Abstract Vascular endothelial growth factor (VEGF) plays a critical role during normal embryonic angiogenesis and also in the pathological angiogenesis that occurs in a number of diseases, including cancer. We developed a novel VEGF blockade system using RNA interference. The small interfering RNA (siRNA) targeting human VEGF almost completely inhibited the secretion of VEGF in a human prostate cancer cell line, PC-3, whereas the control scramble siRNA showed no effects. The VEGF siRNA with atelocollagen dramatically suppressed tumor angiogenesis and tumor growth in a PC-3 s.c. xenograft model. Atelocollagen provided a beneficial delivering means by which stabilization and efficient transfection of the siRNA injected into the tumors were achieved.
16
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Andrew Fire, Siqun Xu, Mary K. Montgomery et al. · Nature · 1998 · 15.3K citations · Full text
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
David W. M. Leung, George Cachianes, Wun-Jing Kuang et al. · Science · 1989 · 5K citations
K. Jin Kim, Bing Li, Jane Winer et al. · Nature · 1993 · 3.6K citations
Medicine, Cancer Biology, Oncology +14
VEGF-Trap: A VEGF blocker with potent antitumor effects
Jocelyn Holash, Sam Davis, Susan D. Croll et al. · Proceedings of the National Academy of Sciences · 2002 · 1.7K citations
Medicine, Oncology, Pharmacology +17